The Gross Margin of Kexing Biopharm Co Ltd (688136.SS) is 68.43%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
| Date | Value |
|---|---|
| 2024-12-31 | 68.43% |
| 2023-12-31 | 70.59% |
| 2022-12-31 | 75.33% |
| 2021-12-31 | 79.36% |
| 2020-12-31 | 79.91% |
| 2019-12-31 | 81.48% |
| 2018-12-31 | 81.06% |
| 2017-12-31 | 78.95% |